Amazon is now more valuable than Microsoft. The e-commerce giant's market value increased to $702 billion, surpassing the tech company at $699.2 billion. Apple and Alphabet are still ahead of Amazon in being the most valuable companies.
McDonald's is making Happy Meals healthier. The company says it will cap at least half of all children's offerings at 600 calories by 2022. It's removing the cheeseburger from the menu but will still offer them by request.
Washington D.C. is reacting to the deadliest school shooting since Sandy Hook. Salon's Amanda Marcotte joins Cheddar to break down President Trump's address to the nation. He did not mention guns once in the speech.
The fitness world's boxing trend is getting a new twist at Box + Flow. We talk to Founder Liv Young about why she's adding yoga to the boxing workout at her boutique studio. She left a high-profile branding job in the food industry to live her dream as an entrepreneur.
Blame geography for the U.S. getting hit by stronger, costlier, more varied and frequent extreme weather than anywhere on the planet, several experts said. But that's only part of it.
Residents across a wide swath of the U.S. raced Sunday to assess the destruction from fierce storms that spawned possibly dozens of tornadoes from the South and the Midwest into the Northeast.
The U.S. Food and Drug Administration has approved selling overdose antidote naloxone over-the-counter, marking the first time a opioid treatment drug will be available without a prescription.
Millions of Americans could lose access to Medicaid on April 1, and Joe Dunn, senior vice president of public policy at the National Association of Community Health Centers, joined Cheddar News' anchor Shannon LaNier to discuss what this means for public health.
One third of Americans don't have access to primary care providers in their communities, according to a study from the National Association of Community Health Centers published last month.
Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report.
